Regulating the Wellness Industry by the Inch The Food and Drug Administration (FDA) has been under pressure from consumer advocacy groups and lawmakers to crack down on the peptide market, which is estimated to be worth billions of dollars annually.
Critics argue that many peptide products are untested, unproven, and often marketed with unsubstantiated claims about their health benefits.
Some peptides have already been approved by the FDA for specific medical uses, such as treating hormone deficiencies or certain types of cancer.